High impact
April 2026 Town Hall Presentation
Alaska Medicaid·Effective May 11, 2026
HCPCS J1557 is officially defined as "Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg." HCPCS J1557 is referenced in 1 tracked payer policy change from Alaska Medicaid. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J1557 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.